Concepts of biocompatibility testing.
C. H. J. Hauman & R. M. LoveDepartments of Oral Rehabilitation, and 2Stomatology, School of Dentistry, University of Otago, Dunedin, New Zealand.Biocompatibility is defined as the ability of a material to function in a specific application in the presence of an appropriate host response (Williams 1987). According to EN 1441 (European Committee for Standardization 1996) biocompatible materials must be free of any risks.
Endodontic materials can be broadly categorized as those used to maintain pulp vitality and those used in pulp canal therapy for disinfection of the pulp space (irrigants and intracanal medicaments) and rootcanal filling (solid materials and sealers). Biocompatibility of these endodontic materials is characterized by many parameters such as genotoxicity, mutagenicity, carcinogenicity, cytotoxicity, histocompatibility or microbial effects. It is thus impossible to biologically characterize the materials by a single test method alone and their properties need to be investigated by a battery of various in vitro and in vivo tests in a structured approach.
Autian (1970) was the first to propose a structured approach as a concept consisting of three levels:
- Nonspecific toxicity (cell cultures or small laboratory animals);
- Specific toxicity (usage tests, e.g. in subhuman primates);
- Clinical testing in humans.
According to Autian (1970) the term‘nonspecific’ refers to test systems which do not reflect the application of a material in a clinical situation whilst the term‘specific’ applies to the use of biological models simulating the actual clinical use of the material. The following sequence was adopted by the ISO (1984) in Technical Report 7405:
- Initial tests (cytotoxicity, mutagenicity);
- Secondary tests (sensitization, implantation tests, mucosal irritation);
- Usage tests.
In both concepts, newly developed materials should be subjected to the three steps in the given sequence from the simple to the complicated test method, from in vitro to animal tests and from preclinical to clinical testing on humans.
Cell culture tests.The employment of in vitro tests offers the possibility of studying the effects of the release of material components on cell systems (Pertot et al.1997). Cell culture studies have been used for more than 30 years for the investigation of cytotoxic reactions induced by endodontic materials (Rappaport et al.1964, Keresztesi & Kellner 1966). Permanent cell lines, e.g.HeLa,3T3 or L929 cells and primary/diploid human cells, mainly oral fibroblasts are used for these experiments. Primary cells are considered to be more relevant for biocompatibility studies than permanent cultures (Matsumoto et al. 1989, Al-Nazhan & SpHngberg1990).Various biological endpoints are used for these investigations. They include growth inhibition, determination of the effective dose 50 (ED50), membrane integrity, DNA, RNA or protein synthesis and/or the determination of alterations of cellular morphology by light or electron microscopy (Matsumoto et al. 1989, Al- Nazhan & SpHngberg 1990, McNamara et al. 1992, Barbosa et al.1994, Beltes et al.1995).
Assays have been developed to investigate the influence of dentine on the cytotoxicity of sealers or isolated sealer components, such as the pulp chamber test or the application of a layer of dentine chips mimicking anapical dentine plug (Hanks et al.1989,Meryon &Brook 1990, Schmalz et al.1994, Schmalz & Schweikl1994).
Genotoxicity.In vitro test systems for genotoxicity can be differentiated (Heil et al.1996) into prokaryotic (e.g. Ames test, umutest) and eukaryotic assays (e.g. DNA synthesis inhibition test (DIT). Since various dental or endodontic materials are highly cytotoxic, it is a basic requirement for genotoxicity tests to easily quantify cytotoxicity simultaneously. Moreover, it must be considered that various endodontic filling materials reveal a strong antibacterial activity as has been described by Orstavik (1988) and by Stea et al. (1994). A combination of prokaryotic and eukaryotic tests, e.g. the bacterial umu test (Oda et al. 1985) with the eukaryotic DIT (Painter 1977) supplemented byan in vivo assay (e.g. alkaline filter elution (AFE) assay) (Heil et al.1996), is thus necessary to gain more reliable results with respect to the genotoxicity of endodontic materials.
Tissue reactions to microbes.The possible interactions between endodontic materials and/or its components with microorganisms need to be considered when discussing biocompatibility. Microorganisms may persist within the pulp cavity after root-canal filling, re-infect the canals through coronal leakage or they may proliferate in adjacent tissues (Torabinejad et al.1990, Oguntebi1994).These persisting or re-infecting bacteria may enhance possible adverse effects. It would thus be of great benefit if an endodontic material has biocompatible as well as antibacterial properties. Antimicrobial activity of materials to endodontic pathogens is normally measured using simple tests, e.g. agar diffusion and agar dilution tests (Pumarola et al.1992). Endodontic materials with strong antibacterial activity have frequently been found to induce strong adverse effects during and after treatment and were also found to be cytotoxic and even mutagenic (Orstavik & Hongslo 1985, Heil et al. 1996). Experimentation in vitro has the advantage of easy control of experimental factors, which is one of the most significant problems when performing experiments in vivo. However, the in vitro procedure is not helpful in studying the complex interactions between material and host tissue (Geurtsen & Leyhausen 1997).
Implantation.In vivo nonspecific tissue reactions caused by endodontic materials are normally investigated by histological studies following the implantation of the test material into various tissues of animals. The test material may be directly injected or implanted (either directly or within Teflon, silicone or polyethylene tubes) into various tissues, such as the subcutaneous connective tissue, muscle or bone of rats, rabbits, guinea pigs, hamsters and ferrets (Torneck1961, SpHngberg1969, Binnie &Mitchell 1973, Olsson et al. 1981a, b, Safavi et al. 1983, Thomas et al. 1985,Tagger & Tagger 1986, Orstavik & Mjor 1988, Maher et al. 1992, Pertot et al. 1992,Tassery et al. 1997, Kolokuris et al.1998).
Usage tests.Specific in vivo toxicity tests involve the use of the test material for root-canal therapy in animals, predominantly dogs (Soares et al.1990, Sonat et al.1990, Suzuki et al. 1995, Torabinejad et al. 1995) or monkeys (Torabinejad et al. 1997). In such studies, root canals are either filled to the cemento-dentinal junction or are deliberately overfilled to determine the reaction of the periapical tissue (Sonat et al. 1990). Due to ethical considerations these tests are rarely performed in humans (Lambjerg-Hansen 1987).
Althoughin vivo tests are helpful inunderstandingthe complex interactions between the host and host tissue, the use of animals faces ethical problems and is under public discussion. Furthermore, these tests are expensive, time consuming and are difficult to control (Schmalz1997).
Human studies.Finally, retrospective or preferably controlled prospective clinical studies in humans are necessary to determine long-term biocompatibility of permanent endodontic materials. It must be emphasized that all studies, including well-performed prospective clinical trials, only yield a statistical approximation of the biocompatibility of an oral or endodontic material (Geurtsen 2001). Thus, materials rated with a good biocompatibility may cause adverse reactions in a number of patients.